Filer Snapshot

GLENVIEW CAPITAL MANAGEMENT, LLC

CIK 0001138995. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

61

Latest filing

21 May 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open 13F portfolio Save page

Largest parsed holding

CVS

$588.69M reported value

Open holding

13D/G large stake

GENI

19 May 2026 · 5.2% ownership

Open 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Schedule 13D/G

SCHEDULE 13G filed on 21 May 2026 for CIK 0001138995.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$3.69B

Quarterly institutional holdings reported on Form 13F.

Latest reported 13F value

13F
$3.69B

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Largest 13F holdings

13F
CVS GPN THC AMZN TEVA
+15 moreCI AMD TMO VTRS DXC CNC UBER GTM XYZ META AMAT ONTO DKS HUM BFLY

Largest symbols in the latest parsed Form 13F information table.

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

CVS GPN THC AMZN TEVA CI AMD TMO
+12 moreVTRS DXC CNC UBER GTM XYZ META AMAT ONTO DKS HUM BFLY

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

BFLY

Largest active 13G stakes

Passive or institutional large-stake positions disclosed in parsed Schedule 13G filings.

GTM ALIT DXC GENI MYGN
How to read these SEC ownership signals
  • Read each filing family separately: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different SEC disclosure questions.
  • Open the linked research path when you need the filing, CIK, issuer, or CUSIP trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
520 Madison Avenue, 33 Rd Floor, New York, NY, 10022
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
DE
Fiscal year end
31 December

Filer intelligence

What SEC filings say about GLENVIEW CAPITAL MANAGEMENT, LLC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Open 13F portfolio Save filer

Quick read

  • Latest parsed 13F shows $3.69B across 41 reported holdings for Q1 2026.
  • Largest parsed 13F holding: CVS at $588.69M.
  • 5 recent 13D/G stake rows found; top row is GENI at 5.2% ownership.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 41 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes 5 rows

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q1 2026 - 15 May 2026

Top 5 concentration

47%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$1.73B

Compared with $3.69B total 13F value.

Top 5 net change

-$328.8M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: META · Largest trim: TEVA

CVS GPN THC AMZN TEVA Other holdings

CVS

15.9%

Cvs Health Corp

$588.69M

GPN

11.6%

Global Pmts Inc

$428.05M

THC

7.8%

Tenet Healthcare Corp

$287.76M

AMZN

6%

Amazon Com Inc

$220.61M

TEVA

5.4%

Teva Pharmaceutical Inds Ltd

$200.61M

13D/G large-stake context

GENI

19 May 2026 · Ordinary Shares

5.2%
Issuer page 13D/G history

DXC

20 Mar 2026 · Common Stock, $0.01 par value per share

5.2%
Issuer page 13D/G history

BFLY

12 Feb 2026 · Class A common stock, par value $0.0001 per share

8.5%
Issuer page 13D/G history

MYGN

06 Jan 2026 · Common Stock, par value $0.01 per share

5.3%
Issuer page 13D/G history

Latest update

What changed recently for GLENVIEW CAPITAL MANAGEMENT, LLC

New filing available

Latest Schedule 13D/G period: 19 May 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

21 May 2026

Page type

Filer profile

Latest period

19 May 2026

Schedule 13D/G context is visible from filings filed on 21 May 2026.

Open filer profile Browse recent public updates

Benchmark Context

Benchmark context for this company

GLENVIEW CAPITAL MANAGEMENT, LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest Schedule 13D/G period: 19 May 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

SEC filing record

CIK 0001138995 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
61
First seen
14 Feb 2014
Latest filing
21 May 2026
Entity
Company

Observed form types

13F-HR 13F-HR/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A

CIK-linked evidence first

GLENVIEW CAPITAL MANAGEMENT, LLC SEC filings GLENVIEW CAPITAL MANAGEMENT, LLC 13F portfolio GLENVIEW CAPITAL MANAGEMENT, LLC 13D/G history Open SEC filing index

Latest Filings

Showing the latest 12 of 61 SEC filings for GLENVIEW CAPITAL MANAGEMENT, LLC.

Open full filing history
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
21 May 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
15 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
27 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
17 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
13 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
24 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Nov 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Aug 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
11 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
17 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .